| Antivirals against influenza virus, a (re-)emerging virus with pandemic potential – what are the options | |  | | 2026 | 2 | 0 |
|
| An integrated surveillance study of SARS-CoV-2, influenza virus, and respiratory syncytial virus infections | CMI communications | | | 2026 | 31 | 146 |
|
| Disseminated mpox in an immunocompromised patient in DR Congo : a call for a shift from disease-focused to person-centred outbreak response | Lancet. Infectious diseases | | | 2025 | 6 | 8 |
|
| Prevalence and factors associated with severe fatigue 2 years into the COVID-19 pandemic : a cross-sectional population-based study in Geneva, Switzerland | BMJ open | | | 2025 | 116 | 305 |
|
| Community transmission of mpox clade Ib not driven through sexual exposures, Uvira, eastern Democratic Republic of the Congo, June to October 2024 | Eurosurveillance | | | 2025 | 7 | 25 |
|
| Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout : a cross-sectional analysis of a cohort study | BMC public health | | | 2025 | 94 | 536 |
|
| Biopsychosocial risk factors for subjective cognitive decline among older adults during the COVID-19 pandemic : a population-based study | Public health | | | 2024 | 27 | 253 |
|
| Which trial do we need ? Randomized, placebo-controlled trial of antiviral treatment in patients hospitalized for influenza | Clinical microbiology and infection | | | 2024 | 39 | 369 |
|
| Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary center | CMI communications | | | 2024 | 74 | 169 |
|
| Mental health trajectories among the general population and higher-risk groups following the COVID-19 pandemic in Switzerland, 2021-2023 | Journal of affective disorders | | | 2024 | 19 | 173 |
|
| Identification of a measles variant displaying mutations impacting molecular diagnostics, Geneva, Switzerland, 2023 | Euro surveillance | | | 2024 | 85 | 201 |
|
| Ebola : d'un traitement symptomatique au déploiement de vaccins et de traitements spécifiques | | | | 2024 | 133 | 80 |
|
| Use of complementary medicine and its association with SARS-CoV-2 vaccination during the COVID-19 pandemic : a longitudinal cohort study | Swiss medical weekly | | | 2023 | 80 | 201 |
|
| The longitudinal study of subjective wellbeing and absenteeism of healthcare workers considering post-COVID condition and the COVID-19 pandemic toll | Scientific reports | | | 2023 | 166 | 49 |
|
| Trends in management and outcomes of COVID patients admitted to a Swiss tertiary care hospital | Scientific reports | | | 2023 | 217 | 169 |
|
| Hepatitis E Virus Infection Epidemiology in Recipients of Allogeneic Hematopoietic Cell Transplant | Open forum infectious diseases | | | 2023 | 77 | 162 |
|
| Different virus, same mistakes: Why (re-) emerging viruses are one step ahead of us | The Innovation | | | 2022 | 272 | 112 |
|
| Spécificités de l’infection à SARS-CoV-2 chez les patients âgés | Revue médicale suisse | | | 2022 | 85 | 133 |
|
| One-year persistent symptoms and functional impairment in SARS-CoV-2 positive and negative individuals | Journal of internal medicine | | | 2022 | 285 | 147 |
|
| Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study | Journal of clinical medicine | | | 2022 | 183 | 206 |
|
| Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | | | 2022 | 298 | 248 |
|
| Bas les masques, et après ? | Revue médicale suisse | | | 2022 | 77 | 112 |
|
| The pandemic toll and post-acute sequelae of SARS-CoV-2 in healthcare workers at a Swiss University Hospital | Preventive medicine reports | | | 2022 | 268 | 205 |
|
| Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2 | Nature medicine | | | 2022 | 291 | 527 |
|
| The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization | Scientific reports | | | 2022 | 235 | 137 |
|
| Characteristics of long-COVID among older adults: a cross-sectional study | International journal of infectious diseases | | | 2022 | 174 | 288 |
|
| Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR) | Swiss medical weekly | | | 2021 | 426 | 186 |
|
| Maladies infectieuses | Revue médicale suisse | | | 2021 | 401 | 131 |
|
| Feasibility and safety of rVSV-ZEBOV vaccination of humanitarian health workers against Ebola virus disease: an observational study | Journal of travel medicine |  | | 2021 | 236 | 0 |
|
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | | | 2021 | 534 | 391 |
|
| Novel SARS-CoV-2 variants: the pandemics within the pandemic | Clinical Microbiology and Infection | | | 2021 | 285 | 611 |
|
| Puumala Virus Infection in Family, Switzerland | Emerging Infectious Diseases | | | 2021 | 469 | 513 |
|
| Traitement du SARS-CoV-2 en pédiatrie : quelles évidences et quelle utilité ? | Revue médicale suisse | | | 2021 | 208 | 206 |
|
| Risk of reinfection after seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A population-based propensity-score matched cohort study | Clinical Infectious Diseases | | | 2021 | 518 | 377 |
|
| Covid-19: a puzzle with many missing pieces | BMJ (Clinical Research Edition) | | | 2020 | 350 | 727 |
|
| Diagnostic challenges of central nervous system infection: extensive multiplex panels versus stepwise guided approach | Clinical microbiology and infection | | | 2020 | 108 | 408 |
|
| Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV | PLoS biology | | | 2020 | 110 | 42 |
|
| Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs | Swiss Medical Weekly | | | 2020 | 520 | 566 |
|
| Clinical features of covid-19 | BMJ | | | 2020 | 324 | 1 |
|
| Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | | | 2020 | 531 | 244 |
|
| Dexamethasone and remdesivir: finding method in the COVID-19 madness | The Lancet microbe | | | 2020 | 261 | 61 |
|
| Understanding the emerging coronavirus: what it means for health security and infection prevention | Journal of Hospital Infection | | | 2020 | 268 | 220 |
|
| New filovirus disease classification and nomenclature | Nature Reviews Microbiology | | | 2019 | 408 | 0 |
|
| Ebola Virus Shedding and Transmission: Review of Current Evidence | The Journal of Infectious Diseases | | | 2016 | 567 | 684 |
|
| Ebola virus disease diagnosis by real-time RT-PCR: A comparative study of 11 different procedures | Journal of clinical virology | | | 2016 | 680 | 519 |
|
| Clinical Management of Ebola Virus Disease in the United States and Europe | New England Journal of Medicine | | | 2016 | 1,237 | 390 |
|
| Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone | Clinical infectious diseases | | | 2016 | 654 | 525 |
|
| Sequelae of Ebola virus disease: the emergency within the emergency | The Lancet Infectious Diseases | | | 2016 | 475 | 0 |
|
| The 2014–2015 Ebola outbreak in West Africa: Hands On | Antimicrobial Resistance and Infection Control | | | 2016 | 555 | 283 |
|
| Ebola: le point au crépuscule d'une épidémie inattendue | Revue médicale suisse | | | 2015 | 149 | 361 |
|
| Infectiologie en 2014: une année virale | Revue médicale suisse | | | 2015 | 516 | 2 |
|
| Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case report | Lancet. Infectious diseases | | | 2015 | 724 | 1 |
|
